Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2026-03-09 @ 1:59 AM
Study NCT ID:
NCT00543504
Status:
COMPLETED
Last Update Posted:
2020-06-30
First Post:
2007-10-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab in Multiple Phase I Combinations
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2006-0638
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None